Key Takeaways
- Former Cincinnati Bengals and Houston Texans running back Joe Mixon has informed close friends and former teammates that he does not intend to return to the NFL.
- Mixon last saw game action in the 2024 season with the Texans; a foot injury forced him to miss the entire 2025 campaign and ultimately led to his release in March 2026.
- Ongoing blood‑flow complications in the injured foot have required additional surgery, casting doubt on any realistic comeback.
- While a source told KPRC‑2’s Aaron Wilson there remains “some hope” of a return, Wilson and Mixon’s inner circle believe his playing career is effectively over.
- The news adds to a growing list of talented running backs whose careers have been curtailed by persistent lower‑body injuries, raising questions about player longevity and injury management in the modern NFL.
Former Cincinnati Bengals and Houston Texans running back Joe Mixon has reportedly told former teammates and friends that his NFL career is finished. The revelation came during a Tuesday livestream hosted by KPRC‑2 Houston’s Aaron Wilson, who cited a source close to Mixon indicating that the running back has privately conceded he will not suit up again. Wilson noted that while there is a sliver of optimism expressed by some close to Mixon—“some hope, but I think it’s probably over”—the prevailing sentiment among those who know him best is that he has moved on from professional football.
Mixon’s last appearance on the field came in the 2024 season, his first year with the Houston Texans after spending four productive years with the Cincinnati Bengals. During his time in Cincinnati, Mixon emerged as a dual‑threat back, amassing over 3,500 rushing yards and 20 touchdowns while also contributing as a receiver out of the backfield. His 2021 season with the Bengals stood out, as he rushed for 1,205 yards and scored 13 touchdowns, helping Cincinnati reach the Super Bowl LVI appearance. After signing a two‑year deal with Houston in 2023, Mixon’s production began to dip, hampered by nagging injuries that limited his availability and effectiveness.
The turning point arrived late in the 2024 season when Mixon suffered a significant foot injury. Initial evaluations pointed to a soft‑tissue issue, but imaging revealed compromised blood flow to the affected area—a condition that can impede healing and increase the risk of chronic complications. Mixon underwent surgery to address the problem, but postoperative recovery stalled. Despite a rigorous rehabilitation program, the running back was unable to regain the necessary strength and mobility to participate in team activities throughout the entire 2025 season. Consequently, the Texans placed him on the reserve/injured list for the year and, after assessing his long‑term prognosis, released him in March 2026.
Since his release, Mixon has reportedly consulted with multiple specialists regarding the persistent vascular issues in his foot. According to Wilson, Mixon “recently” underwent another surgical procedure aimed at restoring adequate circulation, a step that suggests the injury’s complexity extends beyond a simple bone or ligament problem. The continued focus on blood flow underscores the seriousness of the ailment; vascular complications in the lower extremities can lead to delayed wound healing, increased pain, and a heightened risk of further injury if an athlete returns to high‑impact activity too soon.
Wilson’s livestream also highlighted the emotional dimension of Mixon’s decision. The running back has reportedly confided in former Bengals teammates—players with whom he shared locker‑room camaraderie and on‑field successes—that he feels it is time to step away from the game. Those conversations appear to have been influenced not only by the physical toll of the injury but also by a desire to prioritize long‑term health and quality of life beyond football. Mixon’s representatives have not issued an official statement, but the consistency of the reports from those close to him suggests a settled mindset.
The news places Mixon alongside a growing cadre of talented running backs whose careers have been truncated by persistent lower‑body ailments. Recent examples include players like Darrell Henderson, Sony Michel, and even former stars such as Adrian Peterson, who have faced similar challenges with foot and ankle injuries that resisted conventional treatment protocols. The trend raises broader questions about how NFL teams manage player workload, the effectiveness of current medical interventions for vascular injuries, and the potential need for evolved preventive strategies—such as customized load‑monitoring, advanced imaging techniques, and regenerative therapies—to extend athletes’ careers.
While Mixon’s departure from the NFL marks the end of a chapter that featured both highlight‑reel runs and frustrating injury setbacks, his legacy remains intact among fans who remember his explosiveness, vision, and ability to break tackles. His time in Cincinnati, highlighted by a breakout 2020 season and a pivotal role in the Bengals’ Super Bowl run, will be remembered as a period when he emerged as one of the league’s most promising young backs. In Houston, despite the injury‑plagued tenure, Mixon continued to demonstrate professionalism and a work ethic that earned him respect in the locker room.
Looking ahead, Mixon’s next steps are uncertain but likely to involve a focus on health, possible business ventures, or perhaps a transition into coaching or mentorship roles within the sport. For now, the consensus among those who know him best is clear: the gridiron will no longer be his primary arena, and the football world will reflect on what might have been had his foot held up to the demands of an NFL running back’s grind.
This summary will be updated as additional information becomes available.